Hypertriglyceridemia therapeutics encompass a range of lipid-lowering agents—fibrates, omega-3 fatty acid formulations, niacin, statins, and emerging RNA-based therapies—that target elevated triglyceride levels to reduce pancreatitis risk and improve cardiovascular outcomes. These treatments offer distinct advantages: fibrates activate peroxisome proliferator-activated receptors to en... https://zippy-goat-z7kvvr.mystrikingly.com/blog/hypertriglyceridemia-therapeutics-marketgrowth-driven-by-rising-obesity